Filing Details
- Accession Number:
- 0001209191-22-020788
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-23 16:37:20
- Reporting Period:
- 2022-03-21
- Accepted Time:
- 2022-03-23 16:37:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Biosciences Inc. | PCRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1296965 | Marie Kristen Williams | C/O Pacira Biosciences, Inc. 5401 West Kennedy Boulevard, Suite 890 Tampa FL 33609 | Chief Administrative Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-21 | 2,953 | $38.35 | 25,221 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-03-21 | 2,112 | $43.54 | 27,333 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-03-21 | 2,188 | $47.65 | 29,521 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-21 | 7,253 | $72.67 | 22,268 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-03-21 | 2,953 | $0.00 | 2,953 | $38.35 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-03-21 | 2,112 | $0.00 | 2,112 | $43.54 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-03-21 | 2,188 | $0.00 | 2,188 | $47.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,953 | 2028-06-13 | No | 4 | M | Direct | |
| 10,560 | 2029-06-05 | No | 4 | M | Direct | |
| 19,685 | 2030-06-09 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Billionaire Hedge Funds
